After the validation of GATA6-AS1 expression in GC, we silenced and overexpressed GATA6-AS1 in GC cells separately to evaluate its loss-of-function and gain-of-function effects on cell viability, proliferation, and migration in GC. The gene discussed is GATA6; the disease is gastric cancer.